Fusarium: Molecular Diversity and Intrinsic Drug Resistance

Abdullah M S Al-Hatmi; Jacques F Meis; G Sybren de Hoog

doi:10.1371/journal.ppat.1005464

Fusarium: Molecular Diversity and Intrinsic Drug Resistance

PLoS Pathog. 2016 Apr 7;12(4):e1005464. doi: 10.1371/journal.ppat.1005464. eCollection 2016 Apr.

Authors

Abdullah M S Al-Hatmi^{1

2

3}, Jacques F Meis^{4

5}, G Sybren de Hoog^{1

2

6

7}

Affiliations

¹ CBS-KNAW Fungal Biodiversity Centre, Utrecht, the Netherlands.
² Institute of Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, the Netherlands.
³ Directorate General of Health Services, Ministry of Health, Ibri Hospital, Ibri, Oman.
⁴ Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
⁵ Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
⁶ Basic Pathology Department, Federal University of Paraná State, Curitiba, Paraná, Brazil.
⁷ Biological Sciences Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.

No abstract available

Publication types

Review

MeSH terms

Animals
Antifungal Agents / pharmacology*
Drug Resistance / genetics*
Fusarium / drug effects*
Fusarium / isolation & purification*
Genetic Variation / genetics*
Humans
Plant Diseases / microbiology*
Prevalence

Substances

Antifungal Agents

Grants and funding

This study was funded by Ministry of Health, Oman, Formal Agreement no. 28/2014. AMSA received a PhD scholarship from Ministry of Health Oman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.